A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines - Wikidata - wikimedia - TriplyDB

A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines

A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines

http://www.wikidata.org/entity/Q35066132

about

Outer membrane vesicles as platform vaccine technology A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Global transcriptome analysis reveals small RNAs affecting Neisseria meningitidis bacteremia.Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes.Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen.HexR Controls Glucose-Responsive Genes and Central Carbon Metabolism in Neisseria meningitidis.Vaccines, reverse vaccinology, and bacterial pathogenesis.Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis.

P2860

Q26766539-63AE6EC1-2397-44FD-BD60-5BDA7DA898CA Q33601907-3A05D360-7CA2-4A37-82FA-6DF980263A3A Q34270429-84CB7074-E1E3-4238-8CB1-123FEB788023 Q34785389-33C15DD9-5185-48B2-87CE-58874958A7B4 Q35043042-221E8C1B-0A19-46C9-98C2-E47C224662F8 Q35181636-AD96D211-DB4A-4B17-87EC-C1DB7F6109C0 Q35198778-506CBA31-CE36-42E4-819E-183CC1B75795 Q35273041-2B0D002D-B9E4-48A1-9A4C-B58B3F548D46 Q35624257-4C6FF479-00CA-46FB-8A92-1019761AFD19 Q35940761-1CB54EF3-4F1F-4C15-BB58-DA3D04A0EC2A Q35989852-7E17DECF-6E98-4E5D-84F4-6D67C3A1E7B7 Q36175206-8587138F-4268-473C-9D89-17D372CA0A09 Q36513433-C80D325E-404E-42C3-8545-9217878E500C Q37629936-F8A5A3B9-CC0E-43D0-A439-BEF8AC32994E Q38183156-6D0D6E11-B538-471E-9874-5F96EC7FD2AB Q38363907-6E5CE30A-305A-446D-AAA4-2E69AC2E5E81 Q38386703-94C75A98-E2E4-4C4C-B393-8C40494F35C9 Q39426398-D5B49461-1000-4205-84D3-C37D58222420 Q45097394-CBE4F03A-78FC-43B0-BCEE-0E5F5C24AF1D

P2860

A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines

http://www.wikidata.org/entity/Q35066132

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A critical threshold of mening ...... uter membrane vesicle vaccines

@ast

A critical threshold of mening ...... uter membrane vesicle vaccines

@en

type

label

A critical threshold of mening ...... uter membrane vesicle vaccines

@ast

A critical threshold of mening ...... uter membrane vesicle vaccines

@en

prefLabel

A critical threshold of mening ...... uter membrane vesicle vaccines

@ast

A critical threshold of mening ...... uter membrane vesicle vaccines

@en

P1433

Q35066132-BE1A4B94-AC29-48FB-97A0-3EE2EC78B58B

P1476

Q35066132-5210B145-6C15-4E5B-A131-909D51F9A9F1

P2093

Q35066132-5379C50E-5A4B-4631-B526-E7CF189CFCBC

Q35066132-845C1828-97BE-4D93-A70D-B80B0C89E0FF

Q35066132-9FF80B5A-4711-41E1-8349-46EA096DC8FC

P2860

Q35066132-09652C18-7829-49A0-BFB6-5A445CCF86A0

Q35066132-0A77CDE0-551E-45F2-AC18-7AAB565D825D

Q35066132-1263FC61-1CCA-4989-9AC6-D6BC9720C2D8

Q35066132-250B1D66-D93A-44F5-849A-DE1699EFFE5E

Q35066132-2C2B1D8F-71A0-4539-9E2C-7D2C7D628157

Q35066132-3044ED36-7094-4A5D-851F-0F1BF67246CF

Q35066132-30F78DF3-E70B-4807-9BC3-1BCEB6D2E0CD

Q35066132-32FE1597-D8AA-483B-A24F-2174014C1142

Q35066132-37C2E230-762C-4E2A-BE85-42F914A19767

Q35066132-4731067F-C64A-459F-9F6A-09D0F29CD5B9

P304

Q35066132-B1C37D3F-FACC-43C8-8DBC-49CCD9449162

P31

Q35066132-BAF07486-DAA0-4464-A04C-65D1E7D7DD87

P356

Q35066132-A05B160F-4FD5-4A59-8983-18D983FF364E

P433

Q35066132-9C6EEB26-8E5D-40AA-803B-037963DB9BB2

P478

Q35066132-9E1BC9C2-BFBF-47E4-9A80-87D9C580B4CA

P577

Q35066132-B0799A23-B8A2-4FF8-92EC-0E007B017609

P5875

Q35066132-1F93738D-6B2A-4344-A552-29D5E34198F8

P698

Q35066132-C9CB4F72-8760-406C-9082-E3EC84491EA4

P932

Q35066132-57478A9D-4A31-4DD3-BFCF-9872C14497EA

P356

P1433

Clinical and Vaccine Immunology

P1476

A critical threshold of mening ...... uter membrane vesicle vaccines

@en

P2093

Dan M Granoff

http://www.w3.org/2001/XMLSchema#string

Isabel Delany

http://www.w3.org/2001/XMLSchema#string

Oliver Koeberling

http://www.w3.org/2001/XMLSchema#string

P2860

Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein

Functional genomics of Neisseria meningitidis pathogenesis.

Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.

Review of meningococcal group B vaccines.

Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.

Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.

The modular architecture of meningococcal factor H-binding protein.

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.

Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults.

P304

736-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00542-10

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50266970

http://www.w3.org/2001/XMLSchema#string

P698

21367981

http://www.w3.org/2001/XMLSchema#string

P932

3122520

http://www.w3.org/2001/XMLSchema#string